Usefulness of Heart Rate at Rest as a Predictor of Mortality, Hospitalization for Heart Failure, Myocardial Infarction, and Stroke in Patients With Stable Coronary Heart Disease (Data from the Treating to New Targets [TNT] Trial)

American Journal of Cardiology

Volumn 105, Issue 7, 2010, Pages 905-911

  Ho, Jennifer E ^a   Bittner, Vera ^b   DeMicco, David A ^c   Breazna, Andrei ^c   Deedwania, Prakash C ^d   Waters, David D ^a  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

^b University of Alabama at Birmingham   (United States)

^c PFIZER INC   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; FEMALE; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HEART RATE; HOSPITALIZATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OPEN STUDY; OUTCOME ASSESSMENT; POST HOC ANALYSIS; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REST; RISK ASSESSMENT; STROKE;

CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART RATE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; REST; STROKE;

EID: 77949717083     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.11.035     Document Type: Article

References (31)

1. Palatini P., Dorigatti F., Zaetta V., Mormino P., Mazzer A., Bortolazzi A., D'Este D., Pegoraro F., Milani L., Mos L., and Group H.S. Heart rate as a predictor of development of sustained hypertension in subjects screened for stage 1 hypertension: the HARVEST study. J Hypertens 24 (2006) 1873-1880
2. Benetos A., Rudnichi A., Thomas F., Safar M., and Guize L. Influence of heart rate on mortality in a French population: role of age, gender, and blood pressure. Hypertension 33 (1999) 44-52
3. Diaz A., Bourassa M.G., Guertin M.C., and Tardif J.C. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J 26 (2005) 967-974
4. Copie X., Hnatkova K., Staunton A., Fei L., Camm A.J., and Malik M. Predictive power of increased heart rate versus depressed left ventricular ejection fraction and heart rate variability for risk stratification after myocardial infarction: results of a two-year follow-up study. J Am Coll Cardiol 27 (1996) 270-276
5. Fox K., Ford I., Steg P.G., Tendera M., Robertson M., Ferrari R., and BEAUTIFUL Investigators. Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial. Lancet 372 (2008) 817-821
6. Hansen T.W., Thijs L., Boggia J., Li Y., Kikuya M., Björklund-Bodegård K., Richart T., Ohkubo T., Jeppesen J., Torp-Pedersen C., Lind L., Sandoya E., Imai Y., Wang J., Ibsen H., O'Brien E., Staessen J.A., and IDoABPiRtCO Investigators. Prognostic value of ambulatory heart rate revisited in 6928 subjects from 6 populations. Hypertension 52 (2008) 229-235
7. Grassi G., Vailati S., Bertinieri G., Seravalle G., Stella M.L., Dell'Oro R., and Mancia G. Heart rate as marker of sympathetic activity. J Hypertens 16 (1998) 1635-1639
8. Chatzizisis Y.S., Coskun A.U., Jonas M., Edelman E.R., Feldman C.L., and Stone P.H. Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior. J Am Coll Cardiol 49 (2007) 2379-2393
9. Waters D.D., Guyton J.R., Herrington D.M., McGowan M.P., Wenger N.K., Shear C., and TNT Investigators. Treating to New Targets (TNT) study: does lowering low-density lipoprotein cholesterol levels below currently recommended guidelines yield incremental clinical benefit?. Am J Cardiol 93 (2004) 154-158
10. LaRosa J.C., Grundy S.M., Waters D.D., Shear C., Barter P., Fruchart J.C., Gotto A.M., Greten H., Kastelein J.J., Shepherd J., Wenger N.K., and TNT Investigators. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 352 (2005) 1425-1435
11. Khush K.K., Waters D.D., Bittner V., Deedwania P.C., Kastelein J.J., Lewis S.J., and Wenger N.K. Effect of high-dose atorvastatin on hospitalizations for heart failure: subgroup analysis of the Treating to New Targets (TNT) study. Circulation 115 (2007) 576-583
12. Kannel W.B., Kannel C., Paffenbarger R.S., and Cupples L.A. Heart rate and cardiovascular mortality: the Framingham study. Am Heart J 113 (1987) 1489-1494
13. Gillum R.F., Makuc D.M., and Feldman J.J. Pulse rate, coronary heart disease, and death: the NHANES I epidemiologic follow-up study. Am Heart J 121 (1991) 172-177
14. Gillman M.W., Kannel W.B., Belanger A., and D'Agostino R.B. Influence of heart rate on mortality among persons with hypertension: the Framingham study. Am Heart J 125 (1993) 1148-1154
15. Palatini P., Thijs L., Staessen J.A., Fagard R.H., Bulpitt C.J., Clement D.L., de Leeuw P.W., Jaaskivi M., Leonetti G., Nachev C., O'Brien E.T., Parati G., Rodicio J.L., Roman E., Sarti C., Tuomilehto J., and Syst-Eur Trial Investigators. Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension. Arch Intern Med 162 (2002) 2313-2321
16. Zuanetti G., Mantini L., Hernández-Bernal F., Barlera S., di Gregorio D., Latini R., and Maggioni A.P. Relevance of heart rate as a prognostic factor in patients with acute myocardial infarction: insights from the GISSI-2 study. Eur Heart J 19 Suppl F (1998) F19-F26
17. Disegni E., Goldbourt U., Reicher-Reiss H., Kaplinsky E., Zion M., Boyko V., and Behar S. The predictive value of admission heart rate on mortality in patients with acute myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial. J Clin Epidemiol 48 (1995) 1197-1205
18. Kolloch R., Legler U.F., Champion A., Cooper-Dehoff R.M., Handberg E., Zhou Q., and Pepine C.J. Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the INternational VErapamil-SR/trandolapril STudy (INVEST). Eur Heart J 29 (2008) 1327-1334
19. Mauss O., Klingenheben T., Ptaszynski P., and Hohnloser S.H. Bedside risk stratification after acute myocardial infarction: prospective evaluation of the use of heart rate and left ventricular function. J Electrocardiol 38 (2005) 106-112
20. Lee K.L., Woodlief L.H., Topol E.J., Weaver W.D., Betriu A., Col J., Simoons M., Aylward P., Van de Werf F., Califf R.M., and GUSTO-I Investigators. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction: results from an international trial of 41,021 patients. Circulation 91 (1995) 1659-1668
21. Dyer A.R., Persky V., Stamler J., Paul O., Shekelle R.B., Berkson D.M., Lepper M., Schoenberger J.A., and Lindberg H.A. Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. Am J Epidemiol 112 (1980) 736-749
22. Kjekshus J.K. Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials. Am J Cardiol 57 (1986) 43F-49F
23. Carnethon M.R., Golden S.H., Folsom A.R., Haskell W., and Liao D. Prospective investigation of autonomic nervous system function and the development of type 2 diabetes: the Atherosclerosis Risk In Communities study, 1987-1998. Circulation 107 (2003) 2190-2195
24. Liao D., Cai J., Barnes R.W., Tyroler H.A., Rautaharju P., Holme I., and Heiss G. Association of cardiac autonomic function and the development of hypertension: the ARIC study. Am J Hypertens 9 (1996) 1147-1156
25. Lucini D., Riva S., Pizzinelli P., and Pagani M. Stress management at the worksite: reversal of symptoms profile and cardiovascular dysregulation. Hypertension 49 (2007) 291-297
26. Yusuf S., Hawken S., Ounpuu S., Dans T., Avezum A., Lanas F., McQueen M., Budaj A., Pais P., Varigos J., and Lisheng L. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364 (2004) 937-952
27. Bangalore S., Sawhney S., and Messerli F.H. Relation of beta-blocker-induced heart rate lowering and cardioprotection in hypertension. J Am Coll Cardiol 52 (2008) 1482-1489
28. Panza J.A., Diodati J.G., Callahan T.S., Epstein S.E., and Quyyumi A.A. Role of increases in heart rate in determining the occurrence and frequency of myocardial ischemia during daily life in patients with stable coronary artery disease. J Am Coll Cardiol 20 (1992) 1092-1098
29. Ingwall J.S., and Weiss R.G. Is the failing heart energy starved?. On using chemical energy to support cardiac function. Circ Res 95 (2004) 135-145
30. Giannoglou G.D., Chatzizisis Y.S., Zamboulis C., Parcharidis G.E., Mikhailidis D.P., and Louridas G.E. Elevated heart rate and atherosclerosis: an overview of the pathogenetic mechanisms. Int J Cardiol 126 (2008) 302-312
31. Heidland U.E., and Strauer B.E. Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption. Circulation 104 (2001) 1477-1482